PL

Paul Laviolette

CEO and Co-Chairman, Pulse Biosciences; Managing Partner, SV Health Investors

Boston, Massachusetts

Investor
VC

Invests in

  • Min Investment:

    $100,000.00

  • Max Investment:

    $5,000,000.00

  • Target Investment:

    $1,500,000.00

Skills

Start-ups
Commercialization
Venture Capital
Leadership
Medical Devices
Mergers
Business Strategy
Due Diligence
Strategic Planning
Private Equity
Mergers & Acquisitions
Healthcare
Market Development
Strategy
Biotechnology
Executive Management
Financial Modeling
Corporate Development
Cross-functional Team Leadership
Competitive Analysis

Education

Lists including Paul

AM
AR
AB
AF

Based in Boston & Cambridge

668 people

AT
AS
AT
AH

All Series A Investors

14748 people

AM
AT
AS
AR

All Seed Investors

19691 people

Investments

CSA Medical

Series B

Total Funding: $140M

Zerigo Health

Series A

Total Funding: $61M

CardioKinetix

Series E

Total Funding: $110M

ValenTx

Series B

Total Funding: $22M

CardioFocus

Series C

Total Funding: $41M

Soffio Medical

Seed

Total Funding: $3M

Asensus Surgical

Post Ipo Equity

Total Funding: $55M

Work Experience

SI
SpectraWAVE, Inc.

2024

  • Chairman

    2024

PB
Pulse Biosciences, Inc.

2024

  • CEO and Co-Chairman

    2024

SH
SV Health Investors

2008

  • Managing Partner & Chief Operating Officer

    2008

MC
Medtech Convergence Fund

2020

  • Managing Partner

    2020

VM
Vibrato Medical, Inc.

2022

  • Director

    2022

DC
Deerfield Catalyst

2022

  • Director

    2022

EL
Edwards Lifesciences

2020

  • Director

    2020

MG
Mass General Brigham Innovation

2016

  • Chairman

    2016

CM
CSA Medical Inc

2016

  • Director

    2016

CM
Corvia Medical, Inc.

2012

  • Chairman

    2012